180 related articles for article (PubMed ID: 22406657)
1. Population pharmacokinetics of carbamazepine in elderly patients.
Punyawudho B; Ramsay ER; Brundage RC; Macias FM; Collins JF; Birnbaum AK
Ther Drug Monit; 2012 Apr; 34(2):176-81. PubMed ID: 22406657
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
Jiao Z; Shi XJ; Zhao ZG; Zhong MK
J Clin Pharm Ther; 2004 Jun; 29(3):247-56. PubMed ID: 15153086
[TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetics of carbamazepine in adults with epilepsy.
Graves NM; Brundage RC; Wen Y; Cascino G; So E; Ahman P; Rarick J; Krause S; Leppik IE
Pharmacotherapy; 1998; 18(2):273-81. PubMed ID: 9545146
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics of Topiramate in Japanese Pediatric and Adult Patients With Epilepsy Using Routinely Monitored Data.
Takeuchi M; Yano I; Ito S; Sugimoto M; Yamamoto S; Yonezawa A; Ikeda A; Matsubara K
Ther Drug Monit; 2017 Apr; 39(2):124-131. PubMed ID: 28230619
[TBL] [Abstract][Full Text] [Related]
5. Estimation of apparent clearance of valproic acid in adult Saudi patients.
Alqahtani S; Alandas N; Alsultan A
Int J Clin Pharm; 2019 Aug; 41(4):1056-1061. PubMed ID: 31222537
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of carbamazepine in Singapore epileptic patients.
Chan E; Lee HS; Hue SS
Br J Clin Pharmacol; 2001 Jun; 51(6):567-76. PubMed ID: 11422016
[TBL] [Abstract][Full Text] [Related]
7. Serum carbamazepine concentrations in elderly patients: a case-matched pharmacokinetic evaluation based on therapeutic drug monitoring data.
Battino D; Croci D; Rossini A; Messina S; Mamoli D; Perucca E
Epilepsia; 2003 Jul; 44(7):923-9. PubMed ID: 12823575
[TBL] [Abstract][Full Text] [Related]
8. Optimal Dosing Regimen of Phenytoin for Korean Epilepsy Patients: From Premature Babies to the Elderly.
Guk J; Lee SG; Chae D; Kim JH; Park K
J Pharm Sci; 2019 Aug; 108(8):2765-2773. PubMed ID: 30940470
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing topiramate clearance in adult patients with epilepsy: A population pharmacokinetic analysis.
Bae EK; Lee J; Shin JW; Moon J; Lee KJ; Shin YW; Kim TJ; Shin D; Jang IJ; Lee SK
Seizure; 2016 Apr; 37():8-12. PubMed ID: 26908152
[TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetic analysis for 10-monohydroxy derivative of oxcarbazepine in pediatric epileptic patients shows no difference between Japanese and other ethnicities.
Sugiyama I; Bouillon T; Yamaguchi M; Suzuki H; Hirota T; Fink M
Drug Metab Pharmacokinet; 2015 Apr; 30(2):160-7. PubMed ID: 25989891
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic modeling of carbamazepine based on clinical data from Serbian epileptic patients.
Jankovic SM; Jovanovic D; Milovanovic JR
Methods Find Exp Clin Pharmacol; 2008 Nov; 30(9):707-13. PubMed ID: 19229380
[TBL] [Abstract][Full Text] [Related]
12. Development of a population pharmacokinetic model for carbamazepine based on sparse therapeutic monitoring data from pediatric patients with epilepsy.
Carlsson KC; Hoem NO; Glauser T; Vinks AA
Clin Ther; 2005 May; 27(5):618-26. PubMed ID: 15978311
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of steady-state carbamazepine in Egyptian epilepsy patients.
El Desoky ES; Sabarinath SN; Hamdi MM; Bewernitz M; Derendorf H
J Clin Pharm Ther; 2012 Jun; 37(3):352-5. PubMed ID: 21883329
[TBL] [Abstract][Full Text] [Related]
14. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetics of free carbamazepine in adult Omani epileptic patients.
Deleu D; Aarons L; Ahmed IA
Eur J Clin Pharmacol; 2001 Jun; 57(3):243-8. PubMed ID: 11497340
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of unbound and total drug concentrations following intravenously administered carbamazepine in elderly and younger adult patients with epilepsy.
Ahmed GF; Brundage RC; Marino SE; Cloyd JC; Leppik IE; Pennell PB; Ramsay RE; Birnbaum AK
J Clin Pharmacol; 2013 Mar; 53(3):276-84. PubMed ID: 23408495
[TBL] [Abstract][Full Text] [Related]
17. Iron supplements in nursing home patients associated with reduced carbamazepine absorption.
Ahn JE; Bathena SPR; Brundage RC; Conway JM; Leppik IE; Birnbaum AK
Epilepsy Res; 2018 Nov; 147():115-118. PubMed ID: 30327119
[TBL] [Abstract][Full Text] [Related]
18. Population pharmacokinetics of carbamazepine in Chinese epilepsy patients.
Jiao Z; Zhong MK; Shi XJ; Hu M; Zhang JH
Ther Drug Monit; 2003 Jun; 25(3):279-86. PubMed ID: 12766553
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and Saturable Absorption of Gabapentin in Nursing Home Elderly Patients.
Ahmed GF; Bathena SP; Brundage RC; Leppik IE; Conway JM; Schwartz JB; Birnbaum AK
AAPS J; 2017 Mar; 19(2):551-556. PubMed ID: 28070716
[TBL] [Abstract][Full Text] [Related]
20. Estimation of Phenytoin Pharmacokinetic Parameters in Saudi Epileptic Patients.
Alqahtani S; Alzaidi T; Alotaibi M; Alsultan A
Pharmacology; 2019; 104(1-2):60-66. PubMed ID: 31067540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
